CARCINOMA
Clinical trials for CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA trials appear
Sign up with your email to follow new studies for CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted lung cancer drug tested against chemo in phase 3 trial
Disease control TerminatedThis study tested a new targeted pill, pralsetinib, against standard chemotherapy for people with a specific type of advanced lung cancer (RET fusion-positive) who had not yet received treatment. The goal was to see if the targeted drug could delay cancer growth better than chemo…
Matched conditions: CARCINOMA
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 17, 2026 02:06 UTC
-
Kidney cancer combo trial halted early – what we know
Disease control TerminatedThis study tested two new drug combinations for people with advanced clear cell kidney cancer that had already been treated. The goal was to see if adding the experimental drug NKT2152 to standard therapies could shrink tumors or slow the disease. The trial was stopped early, so …
Matched conditions: CARCINOMA
Phase: PHASE2 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
Brain scans and VR aim to decode cancer pain
Knowledge-focused TerminatedThis study explored whether a special brain scan (fNIRS) can measure pain in cancer patients and survivors. Researchers also tested if virtual reality (VR) can help reduce pain by distracting the brain. The goal was to create better, non-drug ways to assess and manage cancer pain…
Matched conditions: CARCINOMA
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC